Vascular disease - clopidogrel and dipyridamole (TA210)
Fast, easy summary view of NICE guidance on 'acute coronary syndrome'
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of technology appraisal guidance 90)
This guidance replaces NICE technology appraisal guidance 90 issued in May 2005.
The review and re-appraisal of clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events has resulted in a change in the guidance. Specifically:
- Treatment with modified-release dipyridamole in combination with aspirin for people who have had an ischaemic stroke is now recommended only if clopidogrel is contraindicated or not tolerated.
- Treatment with modified-release dipyridamole in combination with aspirin for people who have had an ischaemic stroke or a transient ischaemic attack is no longer limited to 2 years’ duration from the most recent event.
- Clopidogrel is no longer recommended only for people who are intolerant of aspirin and have had an occlusive vascular event or have peripheral arterial disease.
Modified-release dipyridamole alone is now recommended as an option to prevent occlusive vascular events.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: acute coronary syndrome
This page was last updated: 23 September 2013
- Web format
- Quick reference guide (PDF)
- Full Guidance (PDF)
- TA210 Clopidogrel a dipyridamole lefel ryddhau wedi'i haddasu er mwyn atal digwyddiadau fasgwlaidd achludol: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.